Does the 1:1:1 Transfusion Ratio Mortality Benefit Hold True in Ultra-massive Transfusion? A Study From the Product (Patient Related Outcomes During Ultra-massive transfusion multi-Center Trial) ConsortiumCourtney Meyer, Jonathan Nguyen, Smith Rn et al.|The American Surgeon|2025Cited by 4